【肺癌】「OncoPrism-NSCLC」: 預測「肺癌」的免疫療法反應獲得國家臨床驗證

 【肺癌】「OncoPrism-NSCLC」: 預測「肺癌」的免疫療法反應獲得國家臨床驗證

 文章出處  

Businesswire 

 

 原文標題  

Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer Patients 

 

 Twitter  

https://x.com/aimedadviser/status/1858312078253269148 

 

 文章序號  

6688 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.